The Nigerian government has assured citizens of the continued availability of HIV treatment drugs despite the temporary suspension of funding from the United States government.
In a statement released on Tuesday, Dr. Adebobola Bashorun, National Coordinator of the National AIDS, Viral Hepatitis and STIs Control Programme (NASCP) under the Federal Ministry of Health and Social Welfare, affirmed that there are sufficient stocks of antiretroviral (ARV) medications across all designated Antiretroviral Therapy (ART) sites nationwide.
“The Federal Government, in collaboration with key implementing partners, has put proactive measures in place to sustain HIV prevention and treatment efforts. There is no cause for alarm,” Bashorun stated.
He explained that NASCP has developed a comprehensive framework and roadmap targeting the triple elimination of HIV, syphilis, and hepatitis B in Nigeria, aligning with the Free to Shine Triple Elimination Campaign spearheaded by the First Lady, Senator Oluremi Tinubu.
The campaign aims to eliminate mother-to-child transmission of these diseases by 2030, with a particular focus on women of reproductive age and children living with or at risk of infection.
To ensure long-term drug availability, Bashorun said NASCP recently conducted a national HIV products quantification exercise for the 2025–2029 period. This initiative, he noted, demonstrates the government’s commitment to commodity security for both the National Treatment and the Prevention of Mother-to-Child Transmission (PMTCT) Programme.
In addition, NASCP has implemented several data-driven mechanisms to strengthen the national HIV response. These include validation of Family Index Testing (FIT) data across 15 states and the Federal Capital Territory (FCT), coordination of national HIV estimates, and a comprehensive review of annual national data to track programme performance and improve data quality.
“These efforts are crucial to ensuring that people living with HIV (PLHIV) in Nigeria continue to receive consistent, high-quality care, regardless of external funding challenges,” he added.
